Download 
|
< Back |
| 09 Dec 2025 | |
| Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda (Pembrolizumab), in US and Canada. | |
| View all announcements for Zydus Lifesciences Ltd | Source: BSE India |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback